Yahoo · Oct 10, 2026
Elekta (OM:EKTA B) Unveils New ASTRO Data, Is The Stock Still Below Fair Value?
Elekta (OM:EKTA B) has just put fresh clinical data in front of oncologists at ASTRO, tying its share story to real world outcomes in brain metastases and localized pancreatic cancer. Recent trading reflects that story. Elekta’s share price is now at SEK54.45, with a 30 day share price return of 8.79% and a 90 day gain of 5.93%. However, the year to date share price return is still down 4.05%, while the 1 year total shareholder return of 19.09% contrasts with declines over 3 and 5 years. This...

